KO2

Clariane SEDB:KO2 Stock Report

Market Cap €1.6b
Share Price
€4.40
My Fair Value
AN
AnalystConsensusTarget
€4.95
11.1% undervalued intrinsic discount
1Y141.3%
7D-9.1%
Portfolio Value
View

Clariane SE

DB:KO2 Stock Report

Market Cap: €1.6b

Clariane (KO2) Stock Overview

Provides care home, healthcare facilities and services, and shared living solutions in France, Germany, Benelux, Italy, Spain, and the United Kingdom. More details

KO2 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance0/6
Financial Health1/6
Dividends0/6

KO2 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Clariane SE Competitors

Price History & Performance

Summary of share price highs, lows and changes for Clariane
Historical stock prices
Current Share Price€4.40
52 Week High€5.37
52 Week Low€1.55
Beta0.87
1 Month Change-15.14%
3 Month Change17.79%
1 Year Change141.27%
3 Year Change-69.99%
5 Year Change-86.47%
Change since IPO-88.43%

Recent News & Updates

Recent updates

Shareholder Returns

KO2DE HealthcareDE Market
7D-9.1%0.1%2.5%
1Y141.3%24.8%18.6%

Return vs Industry: KO2 exceeded the German Healthcare industry which returned 24.8% over the past year.

Return vs Market: KO2 exceeded the German Market which returned 18.6% over the past year.

Price Volatility

Is KO2's price volatile compared to industry and market?
KO2 volatility
KO2 Average Weekly Movement8.9%
Healthcare Industry Average Movement5.0%
Market Average Movement5.2%
10% most volatile stocks in DE Market12.2%
10% least volatile stocks in DE Market2.7%

Stable Share Price: KO2's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: KO2's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
200165,000Sophie Boissardwww.clariane.com

Clariane SE provides care home, healthcare facilities and services, and shared living solutions in France, Germany, Benelux, Italy, Spain, and the United Kingdom. The company operates long-term care and short stays nursing homes. It also provides diagnosis outpatient programs; healthcare services comprising medical and full hospitalization services, as well as day hospitalisation and consultations; and operates post-acute and rehabilitation care facilities, mental healthcare clinics, hospital home care networks, and home community nursing facilities.

Clariane SE Fundamentals Summary

How do Clariane's earnings and revenue compare to its market cap?
KO2 fundamental statistics
Market cap€1.63b
Earnings (TTM)-€85.33m
Revenue (TTM)€5.30b
0.3x
P/S Ratio
-19.0x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
KO2 income statement (TTM)
Revenue€5.30b
Cost of Revenue€3.64b
Gross Profit€1.66b
Other Expenses€1.74b
Earnings-€85.33m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-0.24
Gross Margin31.27%
Net Profit Margin-1.61%
Debt/Equity Ratio110.1%

How did KO2 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/31 01:25
End of Day Share Price 2025/07/31 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Clariane SE is covered by 18 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Fraser DonlonBerenberg
Laurent GelebartBNP Paribas Exane
Arnaud CadartCIC Market Solutions (ESN)